NCT00680225 2017-04-12
Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma
New England Retina Associates
Phase 3 Completed
Clinical Trials
6 trialsNCT00765921 2016-12-02
Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma
Massachusetts Eye and Ear Infirmary
Phase 1 Completed
NCT01251978 2016-10-19
Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)
New England Retina Associates
Phase 2 Completed
NCT00750399 2012-04-26
Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma
The New York Eye Cancer Center
Phase 1 Completed
NCT00811200 2009-07-02
TORR
Leiden University Medical Center
Phase 2/3 Unknown
NCT00540930 2007-10-08
Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy
Shields, Shields and Associates
Phase 4 Unknown